City

Boston (1)

Chicago (1)

Montreal (1)

Overall Status

Completed (1)

Enrolling by invitation (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

phase 2/phase 3 (1)

Sponsor

Constantin Polychronakos (1)

Joslin Diabetes Center (1)

United Arab Emirates University (1)

University of Chicago (1)

Collaborator

Intervention

exendin 9-39 (1)

genetic testing for 4 mody genes (gck, hnf1a, hnf4a, hnf1b) (1)

glp-1 (1)

metformin extended release oral tablet (1)

sitagliptin (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

Funder Type

Other (4)

Study Type

Interventional (3)

Observational (1)

monogenic diabetes

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Maturity-onset Diabetes of the Young, Monogenic Diabetes, MODY Trial (Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A,

Not yet recruiting

Maturity-onset Diabetes of the Young
+2 more

Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)

(no location specified)

Oct 19, 2022

Type 1 Diabetes, Monogenic Diabetes Trial in Boston (Metformin Extended Release Oral Tablet, Sitagliptin)

Enrolling by invitation

Type 1 Diabetes
Monogenic Diabetes

Metformin Extended Release Oral Tablet
Sitagliptin

Boston, Massachusetts

Joslin Diabetes Center

Jan 4, 2022

Monogenic Diabetes Misdiagnosed as Type 1

Recruiting

Diabetes Mellitus, Type 1
+6 more

Montreal, Quebec, Canada

The Montreal Children's Hospital

Oct 11, 2019

Monogenic Diabetes Trial in Chicago (GLP-1, Exendin 9-39)

Completed

Monogenic Diabetes

GLP-1
Exendin 9-39

Chicago, Illinois

University of Chicago

Apr 6, 2017